Basic Information


GTO ID GTC3068
Trial ID NCT05415462
Disease Seasonal Influenza
TherapymRNA vaccine
Treatment mRNA-1010
PhasePhase3
Recruitment statusCompleted
TitleA Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older
Year2022
CountryArgentina|Australia|Colombia|Panama|Philippines
Company sponsorModernaTX, Inc.
Other ID(s)mRNA-1010-P301
Vector information
Vectorlipid nanoparticle

Clinical Result

Cohort1: mRNA-1010
Administration route intramuscular injection
Dosage mRNA-1010, single dose of, on Day 1
Age Adult, Older_Adult
Cohort2: Fluarix Tetra
Administration route intramuscular injection
Dosage licensed quadrivalent inactivated seasonal influenza vaccine, single dose, on Day 1
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph